# CoreCivic, Inc.: financial statements, quarterly

CXW · NYSE · CIK 1070985 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cxw.md) · [Financials](/companies/cxw/financials.md) · [Filings](/companies/cxw/filings.md) · [Insiders](/companies/cxw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cxw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [484](/filings/0000950170-24-122939.md) | [491 d](/filings/0001193125-26-060669.md) | [501](/filings/0000950170-25-066616.md) | [490](/filings/0000950170-25-104763.md) | [492](/filings/0001193125-25-269348.md) | [479 d](/filings/0001193125-26-060669.md) | [489](/filings/0001193125-26-211158.md) | [538](/filings/0001193125-26-337295.md) | [580](/filings/0001193125-25-269348.md) | [604 d](/filings/0001193125-26-060669.md) | [615](/filings/0001193125-26-211158.md) | [685](/filings/0001193125-26-337295.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [17.9](/filings/0000950170-24-122939.md) | [17.7 d](/filings/0001193125-26-060669.md) | [18.6](/filings/0000950170-25-066616.md) | [17.1](/filings/0000950170-25-104763.md) | [16.0](/filings/0001193125-25-269348.md) | [15.7 d](/filings/0001193125-26-060669.md) | [15.2](/filings/0001193125-26-211158.md) | [12.5](/filings/0001193125-26-337295.md) | [16.6](/filings/0001193125-25-269348.md) | [17.8 d](/filings/0001193125-26-060669.md) | [17.7](/filings/0001193125-26-211158.md) | [22.3](/filings/0001193125-26-337295.md) |
| Income tax | $m | [5.6](/filings/0000950170-24-122939.md) | [10.3 d](/filings/0001193125-26-060669.md) | [(0.5)](/filings/0000950170-25-066616.md) | [8.6](/filings/0000950170-25-104763.md) | [9.1](/filings/0001193125-25-269348.md) | [5.9 d](/filings/0001193125-26-060669.md) | [7.0](/filings/0001193125-26-211158.md) | [13.7](/filings/0001193125-26-337295.md) | [10.3](/filings/0001193125-25-269348.md) | [9.7 d](/filings/0001193125-26-060669.md) | [14.4](/filings/0001193125-26-211158.md) | [10.4](/filings/0001193125-26-337295.md) |
| Net income | $m | [13.9](/filings/0000950170-24-122939.md) | [26.5 d](/filings/0001193125-26-060669.md) | [9.5](/filings/0001193125-25-269348.md) | [19.0](/filings/0001193125-25-269348.md) | [21.1](/filings/0001193125-25-269348.md) | [19.3 d](/filings/0001193125-26-060669.md) | [25.1](/filings/0001193125-26-337295.md) | [38.5](/filings/0001193125-26-337295.md) | [26.3](/filings/0001193125-25-269348.md) | [26.5 d](/filings/0001193125-26-060669.md) | [37.9](/filings/0001193125-26-337295.md) | [37.1](/filings/0001193125-26-337295.md) |
| Diluted EPS | $ per share | [0.12](/filings/0000950170-24-122939.md) | not reported | [0.08](/filings/0000950170-25-066616.md) | [0.17](/filings/0000950170-25-104763.md) | [0.19](/filings/0001193125-25-269348.md) | not reported | [0.23](/filings/0001193125-26-211158.md) | [0.35](/filings/0001193125-26-337295.md) | [0.24](/filings/0001193125-25-269348.md) | not reported | [0.38](/filings/0001193125-26-211158.md) | [0.37](/filings/0001193125-26-337295.md) |
| Basic EPS | $ per share | [0.12](/filings/0000950170-24-122939.md) | not reported | [0.08](/filings/0000950170-25-066616.md) | [0.17](/filings/0000950170-25-104763.md) | [0.19](/filings/0001193125-25-269348.md) | not reported | [0.23](/filings/0001193125-26-211158.md) | [0.35](/filings/0001193125-26-337295.md) | [0.25](/filings/0001193125-25-269348.md) | not reported | [0.38](/filings/0001193125-26-211158.md) | [0.38](/filings/0001193125-26-337295.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [104](/filings/0000950170-23-059984.md) | [122](/filings/0000950170-25-024745.md) | [111](/filings/0000950170-24-056419.md) | [60.2](/filings/0000950170-24-093575.md) | [108](/filings/0000950170-24-122939.md) | [107](/filings/0001193125-26-060669.md) | [74.5](/filings/0000950170-25-066616.md) | [131](/filings/0000950170-25-104763.md) | [56.6](/filings/0001193125-25-269348.md) | [97.9](/filings/0001193125-26-337295.md) | [210](/filings/0001193125-26-211158.md) | [109](/filings/0001193125-26-337295.md) |
| Current assets | $m | [420](/filings/0000950170-23-059984.md) | [475](/filings/0000950170-25-024745.md) | [426](/filings/0000950170-24-056419.md) | [383](/filings/0000950170-24-093575.md) | [416](/filings/0000950170-24-122939.md) | [450](/filings/0001193125-26-060669.md) | [413](/filings/0000950170-25-066616.md) | [487](/filings/0000950170-25-104763.md) | [472](/filings/0001193125-25-269348.md) | [611](/filings/0001193125-26-337295.md) | [743](/filings/0001193125-26-211158.md) | [667](/filings/0001193125-26-337295.md) |
| Total assets | $m | [3,069](/filings/0000950170-23-059984.md) | [3,105](/filings/0000950170-25-024745.md) | [3,027](/filings/0000950170-24-056419.md) | [2,903](/filings/0000950170-24-093575.md) | [2,914](/filings/0000950170-24-122939.md) | [2,932](/filings/0001193125-26-060669.md) | [3,002](/filings/0000950170-25-066616.md) | [3,072](/filings/0000950170-25-104763.md) | [3,110](/filings/0001193125-25-269348.md) | [3,257](/filings/0001193125-26-337295.md) | [3,368](/filings/0001193125-26-211158.md) | [3,456](/filings/0001193125-26-337295.md) |
| Current liabilities | $m | [304](/filings/0000950170-23-059984.md) | [297](/filings/0000950170-25-024745.md) | [365](/filings/0000950170-24-056419.md) | [266](/filings/0000950170-24-093575.md) | [275](/filings/0000950170-24-122939.md) | [286](/filings/0001193125-26-060669.md) | [267](/filings/0000950170-25-066616.md) | [304](/filings/0000950170-25-104763.md) | [334](/filings/0001193125-25-269348.md) | [369](/filings/0001193125-26-337295.md) | [305](/filings/0001193125-26-211158.md) | [506](/filings/0001193125-26-337295.md) |
| Total liabilities | $m | [1,610](/filings/0000950170-23-059984.md) | [1,628](/filings/0000950170-25-024745.md) | [1,583](/filings/0000950170-24-056419.md) | [1,456](/filings/0000950170-24-093575.md) | [1,438](/filings/0000950170-24-122939.md) | [1,439](/filings/0001193125-26-060669.md) | [1,527](/filings/0000950170-25-066616.md) | [1,594](/filings/0000950170-25-104763.md) | [1,640](/filings/0001193125-25-269348.md) | [1,851](/filings/0001193125-26-337295.md) | [1,972](/filings/0001193125-26-211158.md) | [2,017](/filings/0001193125-26-337295.md) |
| Long-term debt | $m | [1,056](/filings/0000950170-23-059984.md) | [1,083](/filings/0000950170-25-024745.md) | [984](/filings/0000950170-24-056419.md) | [1,007](/filings/0000950170-24-093575.md) | [980](/filings/0000950170-24-122939.md) | [973](/filings/0001193125-26-060669.md) | [970](/filings/0000950170-25-066616.md) | [1,007](/filings/0000950170-25-104763.md) | [1,028](/filings/0001193125-25-269348.md) | [1,205](/filings/0001193125-26-337295.md) | [1,381](/filings/0001193125-26-211158.md) | [1,232](/filings/0001193125-26-337295.md) |
| Current portion of debt | $m | [14.0](/filings/0000950170-23-059984.md) | [11.6](/filings/0000950170-25-024745.md) | [110](/filings/0000950170-24-056419.md) | [11.8](/filings/0000950170-24-093575.md) | [12.0](/filings/0000950170-24-122939.md) | [12.1](/filings/0001193125-26-060669.md) | [13.0](/filings/0000950170-25-066616.md) | [13.9](/filings/0000950170-25-104763.md) | [14.8](/filings/0001193125-25-269348.md) | [15.7](/filings/0001193125-26-337295.md) | [16.6](/filings/0001193125-26-211158.md) | [115](/filings/0001193125-26-337295.md) |
| Shareholders' equity | $m | [1,458](/filings/0000950170-23-059984.md) | [1,478](/filings/0000950170-25-024745.md) | [1,444](/filings/0000950170-24-056419.md) | [1,448](/filings/0000950170-24-093575.md) | [1,476](/filings/0000950170-24-122939.md) | [1,493](/filings/0001193125-26-060669.md) | [1,475](/filings/0000950170-25-066616.md) | [1,478](/filings/0000950170-25-104763.md) | [1,470](/filings/0001193125-25-269348.md) | [1,405](/filings/0001193125-26-337295.md) | [1,396](/filings/0001193125-26-211158.md) | [1,438](/filings/0001193125-26-337295.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [83.7 d](/filings/0000950170-24-122939.md) | [22.3 d](/filings/0001193125-26-060669.md) | [70.4](/filings/0000950170-25-066616.md) | [68.1 d](/filings/0000950170-25-104763.md) | [91.5 d](/filings/0001193125-25-269348.md) | [39.3 d](/filings/0001193125-26-060669.md) | [44.5](/filings/0001193125-26-211158.md) | [96.7 d](/filings/0001193125-26-337295.md) | [53.8 d](/filings/0001193125-25-269348.md) | [(0.4) d](/filings/0001193125-26-060669.md) | [13.8](/filings/0001193125-26-211158.md) | [133 d](/filings/0001193125-26-337295.md) |
| Capital expenditure | $m | [17.6](/filings/0000950170-24-122939.md) | [27.5 d](/filings/0001193125-26-060669.md) | [10.6](/filings/0000950170-25-066616.md) | [18.7](/filings/0000950170-25-104763.md) | [17.8](/filings/0001193125-25-269348.md) | [23.3 d](/filings/0001193125-26-060669.md) | [24.5](/filings/0001193125-26-337295.md) | [34.9](/filings/0001193125-26-337295.md) | [37.7](/filings/0001193125-25-269348.md) | [44.8 d](/filings/0001193125-26-060669.md) | [20.7](/filings/0001193125-26-337295.md) | [38.1](/filings/0001193125-26-337295.md) |
| Dividends paid | $m | [0.0 d](/filings/0000950170-24-122939.md) | [0.0 d](/filings/0001193125-26-060669.md) | [0.0](/filings/0000950170-25-066616.md) | [0.1 d](/filings/0000950170-25-104763.md) | [0.0 d](/filings/0001193125-25-269348.md) | [0.0 d](/filings/0001193125-26-060669.md) | [0.0](/filings/0000950170-25-066616.md) | [0.0 d](/filings/0001193125-26-337295.md) | [0.0 d](/filings/0001193125-25-269348.md) | [0.0 d](/filings/0001193125-26-060669.md) | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-122939.md) | [12.5 d](/filings/0001193125-26-060669.md) | [49.0](/filings/0000950170-25-066616.md) | [20.2 d](/filings/0000950170-25-104763.md) | [0.0 d](/filings/0001193125-25-269348.md) | [8.0 d](/filings/0001193125-26-060669.md) | [50.6](/filings/0001193125-26-211158.md) | [43.3 d](/filings/0001193125-26-337295.md) | [40.0 d](/filings/0001193125-25-269348.md) | [95.1 d](/filings/0001193125-26-060669.md) | [55.1](/filings/0001193125-26-211158.md) | [0.0 d](/filings/0001193125-26-337295.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [117](/filings/0000950170-23-059984.md) | [115](/filings/0000950170-24-056419.md) | [0.1](/filings/0000950170-24-093575.md) | [0.1](/filings/0000950170-24-122939.md) | [112](/filings/0000950170-25-066616.md) | [111](/filings/0000950170-25-104763.md) | [110](/filings/0001193125-25-269348.md) | [109](/filings/0001193125-26-211158.md) | [109](/filings/0001193125-26-337295.md) | [107](/filings/0001193125-25-269348.md) | [98.7](/filings/0001193125-26-211158.md) | [98.9](/filings/0001193125-26-337295.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 98,893,489 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337295.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.